JAC Advance Access originally published online on March 20, 2008
Journal of Antimicrobial Chemotherapy 2008 61(6):1201-1204; doi:10.1093/jac/dkn099
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original research |
Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates
1 Departamento de Genética, Universidade Federal do Rio de Janeiro, CCS—Bloco A, sala A2-120, Cidade Universitária—Ilha do Fundão, Rio de Janeiro RJ 21949-970, Brazil; 2 Hospital Egas Moniz, Lisbon, Portugal; 3 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium 4 Divisão de Genética, Instituto Nacional de Câncer, Rio de Janeiro, RJ, Brazil
Received 21 November 2007; returned 20 January 2008; revised 1 February 2008; accepted 17 February 2008
* Corresponding author. Tel: +55-21-2562-6383; Fax: +55-21-2562-6396; E-mail: masoares{at}biologia.ufrj.br
Objectives: Non-B human immunodeficiency virus (HIV)-1 subtypes possess several amino acid signatures in the viral protease that distinguish them from subtype B, some of which are reported as secondary drug-related mutations. We have previously shown a strong statistical interdependency of residues 71, 89 and 90 in subtype G, but the impact of substitutions on protease inhibitor (PI) resistance is unknown.
Patients and methods: We selected subtype G viruses from patients with diverse amino acid combinations at codons 71 (A/T), 74 (T/S), 89 (I/L/M/V) and 90 (L/M). Viral protease genes were inserted into an HIV molecular clone (HXB2). PI drug susceptibilities of chimeric viruses were determined.
Results: In isolates displaying 89I/V in combination with A71 or T74, a reversal to subtype G wild-type 89M was observed after growth in the absence of PI. The presence of 71T in one isolate and 74S in another allowed the persistence of 89I. Mutation 90M conferred intermediate but significant degrees of drug resistance to ritonavir and nelfinavir in subtype G viruses. The combination of 71T or 74S, 89I and 90M resulted in higher levels of resistance to those PIs.
Conclusions: Our results point to the hypothesis that 71T or 74S stabilizes 89I in the protease of subtype G, whose association was previously seen by Bayesian network analyses. The association of 89I with 90M may further increase the PI resistance of subtype G viruses when compared with 90M alone, highlighting novel mutational profiles for drug resistance in this non-B subtype.
Keywords: PI , phenotype assay , accessory mutations
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. A. Soares, A. F. Santos, L. M. Gonzalez, M. S. Lalonde, D. M. Tebit, A. Tanuri, E. J. Arts, and M. A. Soares Mutation T74S in HIV-1 subtype B and C proteases resensitizes them to ritonavir and indinavir and confers fitness advantage J. Antimicrob. Chemother., November 1, 2009; 64(5): 938 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Santos, A. B. Abecasis, A.-M. Vandamme, R. J. Camacho, and M. A. Soares Discordant genotypic interpretation and phenotypic role of protease mutations in HIV-1 subtypes B and G J. Antimicrob. Chemother., March 1, 2009; 63(3): 593 - 599. [Abstract] [Full Text] [PDF]
|
|